VMNI mejora supervivencia en pacientes con EPOC severa estable
The addition of long-term NPPV to standard treatment improves survival of patients with hypercapnic, stable COPD when NPPV is targeted to greatly reduce hypercapnia.
En Lancet Respiratory Medicine
No hay comentarios:
Publicar un comentario